Komori
Oriental Shiraishi (1786) · InitiativeRestated

Strengthening competitiveness and productivity through research and development and strategic investment

First written in FY2021. 11 of 16 entries say "Restated". Latest entry: FY2027-H1.

16entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021 – FY2023-Q3RestatedFY2024-Q1 – FY2025-H1RestatedFY2026-H1 – FY2027-H12021: 220212022: 320222023: 420232024: 320242025: 220252026: 22026
Same theme, other companies

The whole theme swung hardest in 2023: 2 of 12 companies on the "Worse" side.

3 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 15 companies compared. The sentences above are computed from all 15.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1RestatedAnnual report

    「The total R&D expenses incurred by our group during the interim consolidated accounting period amounted to ¥423 million. There was no material change in the status of our group's R&D activities during the interim consolidated accounting period.」

    The company disclosed R&D expenses of ¥423 million and explained that there had been no material change in the status of its R&D activities. It reaffirmed its policy of continuing R&D.
  2. FY2026Full-year R&D expenses and research themes updatedAnnual report

    「The total R&D expenses incurred by our group during the consolidated fiscal year amounted to ¥901 million.」

    R&D expenses declined from ¥984 million in the previous fiscal year to ¥901 million. The company disclosed research themes covering unmanned and automated construction, remote centralized management, repair and reinforcement, AI-based inspections, the environment and resource circulation, port structures, and occupational health and safety.
  3. FY2026-H1RestatedAnnual report

    「The total R&D expenses incurred by our group during the interim consolidated accounting period amounted to ¥473 million. There was no material change in the status of our group's R&D activities during the interim consolidated accounting period.」

    The company disclosed R&D expenses of ¥473 million and explained that there had been no material change in the status of its R&D activities. It reaffirmed its policy of continuing R&D.
  4. FY2025AdvancedAnnual report

    「The total R&D expenses incurred by our group during the consolidated fiscal year amounted to ¥984 million.」

    R&D expenses increased from ¥745 million in the previous fiscal year to ¥984 million. The company continues and is expanding R&D on unmanned construction, repair and reinforcement, AI-based inspections, port structures, CO2 reduction and resource circulation, and occupational health and safety.
  5. FY2025-H1RestatedAnnual report

    「The total R&D expenses incurred by our group during the interim consolidated accounting period amounted to ¥407 million. There was no material change in the status of our group's R&D activities during the interim consolidated accounting period.」

    The company disclosed R&D expenses of ¥407 million for the interim consolidated accounting period and explained that there had been no material change in the status of its R&D activities. It reaffirmed its policy of continuing R&D.
  6. FY2024Added full-year R&D expenses and research themesAnnual report

    「The total R&D expenses incurred by our group during the consolidated fiscal year amounted to ¥745 million.」

    The company disclosed full-year R&D expenses of ¥745 million and continues R&D on unmanned construction, repair and reinforcement, labor-saving and AI-based bridge inspections, port structures, CO2-reducing concrete and other areas.
  7. FY2024-Q3RestatedAnnual report

    「The total R&D expenses incurred by the Group during the nine months ended the third quarter of the current consolidated fiscal year amounted to ¥572 million. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter of the current consolidated fiscal year.」

    The company disclosed R&D expenses of ¥572 million and explained that there had been no material change in the status of its R&D activities. It reaffirmed its policy of continuing R&D.
  8. FY2024-Q2RestatedAnnual report

    「The total R&D expenses incurred by the Group during the six months ended the second quarter of the current consolidated fiscal year amounted to ¥379 million. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter of the current consolidated fiscal year.」

    The company disclosed R&D expenses of ¥379 million for the six months ended FY2024-Q2 and stated that there were no material changes in the status of its R&D activities. It reaffirmed its policy of continuing R&D.
  9. FY2024-Q1RestatedAnnual report

    「The total R&D expenses incurred by the Group during the three months ended the first quarter of the current consolidated fiscal year amounted to ¥188 million. There were no material changes in the status of the Group's R&D activities during the three months ended the first quarter of the current consolidated fiscal year.」

    R&D expenses for FY2024-Q1 were ¥188 million, and the company stated that there were no material changes in the status of its R&D activities. It reaffirmed its policy of continuing R&D.
  10. FY2023AdvancedAnnual report

    「The total R&D expenses incurred by the Group during the consolidated fiscal year amounted to ¥717 million.」

    The Group incurred ¥717 million in R&D expenses and continues R&D on unmanned and automated operations, repair and reinforcement, IoT and AR, CO2 reduction, and productivity improvement.
  11. FY2023-Q3RestatedAnnual report

    「The total R&D expenses incurred by the Group during the nine months ended the third quarter of the current consolidated fiscal year amounted to ¥546 million. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter of the current consolidated fiscal year.」

    While stating that there were no material changes in R&D activities, the company disclosed R&D expenses of ¥546 million for the nine months ended the third quarter of the current consolidated fiscal year.
  12. FY2023-Q2RestatedAnnual report

    「The total R&D expenses incurred by the Group during the six months ended the second quarter of the current consolidated fiscal year amounted to ¥335 million. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter of the current consolidated fiscal year.」

    While stating that there were no material changes in R&D activities, the company disclosed R&D expenses of ¥335 million for the six months ended the second quarter of the current consolidated fiscal year.
  13. FY2023-Q1RestatedAnnual report

    「The total R&D expenses incurred by the Group during the three months ended the first quarter of the current consolidated fiscal year amounted to ¥154 million. There were no material changes in the status of the Group's R&D activities during the three months ended the first quarter of the current consolidated fiscal year.」

    The company stated that there were no material changes in R&D activities and disclosed R&D expenses of ¥154 million for the three months ended the first quarter of the current consolidated fiscal year.
  14. FY2022-Q3RestatedAnnual report

    「The total R&D expenses incurred by the Group during the nine months ended the third quarter of the current consolidated fiscal year amounted to ¥443 million. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter of the current consolidated fiscal year.」

    The company stated that there were no material changes in R&D activities and disclosed R&D expenses of ¥443 million for the nine months ended the third quarter of the current consolidated fiscal year.
  15. FY2022-Q2RestatedAnnual report

    「The total R&D expenses incurred by the Group during the six months ended the second quarter of the current consolidated fiscal year amounted to ¥290 million. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter of the current consolidated fiscal year.」

    While stating that there were no material changes in R&D activities, the company disclosed R&D expenses of ¥290 million for the six months ended the second quarter of the current consolidated fiscal year.
  16. FY2021First statedAnnual report

    「Focusing on research and development and strategic investment to strengthen competitiveness and improve productivity」

    The Group incurred ¥459 million in R&D expenses and ¥1,185 million in capital investment, positioning R&D and investment as means of improving competitiveness and productivity.
Moved together

"Stable dividends and 40% targets for the payout ratio and total payout ratio" moved the same way as this thread, in the same document, in 2 of its 16 moves.

22222★12345
  1. ★This thread
  2. 1Stable dividends and 40% targets for the payout ratio and total payout ratio2×
  3. 2Strengthening the organization through enhanced training and the use of diverse talent2×
  4. 3Talent development, productivity improvement and work-style reform2×
  5. 4¥20 billion investment over 5 years in facilities, production capacity and research and development2×
  6. 5Increasing Pneumatic Caisson Equipment and Production Capacity2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Oriental Shiraishi yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.